Dr. David W. Goodman's keynote opens with the premise that clinicians and patients alike are drowning in exponentially growing information, creating fertile ground for misinformation to spread faster than it can be corrected. He will trace the development of telepsychiatry over the past years with a focus on the ADHD telehealth company Done.com and its use of a business model masquerading as a medical model, placing patients' safety at risk. The conviction of top executives in this federal case set a new precedent, holding business executives responsible for the illegitimate prescriptions of controlled drugs. 

Misleading advertising by Done.com and the general misinformation available on the internet have become a burdensome challenge for people seeking accurate information on ADHD. Dr. Goodman connects this to consumer-behavior research on influencer trust, parasocial authenticity, and algorithmic reinforcement, arguing the same psychological mechanisms that drive purchasing decisions drive self-diagnosis, often resulting in inaccurate conclusions about their symptoms.

To counter this, Goodman presents evidence that ADHD is a legitimate, neurobiologically grounded diagnosis (delayed cortical maturation, receptor and network differences), while cautioning that clinical research itself has limits that often don't reflect real-world patients. He concludes with the application of these concepts to ensure that patients receive "research-driven, clinically informed, and patient-focused "care